4//SEC Filing
Masoud Maher 4
Accession 0001209191-24-000790
CIK 0001287098other
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 4:30 PM ET
Size
6.1 KB
Accession
0001209191-24-000790
Insider Transaction Report
Form 4
MAXCYTE, INC.MXCT
Masoud Maher
DirectorPresident and CEO
Transactions
- Award
Employee Stock Option (right to buy)
2024-01-03+400,000→ 400,000 totalExercise: $4.42Exp: 2034-01-02→ Common Stock (400,000 underlying)
Footnotes (1)
- [F1]This option grant was made pursuant to the terms of the letter agreement, dated as of December 11, 2023, by and between the Issuer and the reporting person, entered into in connection with his appointment as President and Chief Executive Officer of the Issuer, as set forth in a Current Report on Form 8-K filed by the Issuer on December 11, 2023. Of the shares underlying the option, 25% will vest on January 2, 2025 and the remaining 75% will vest in 36 equal monthly installments thereafter, in each case subject to the reporting person's continuous service with the Issuer at the applicable vesting date.
Documents
Issuer
MAXCYTE, INC.
CIK 0001287098
Entity typeother
Related Parties
1- filerCIK 0001874571
Filing Metadata
- Form type
- 4
- Filed
- Jan 3, 7:00 PM ET
- Accepted
- Jan 4, 4:30 PM ET
- Size
- 6.1 KB